Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Monk

Showing results (251-260 of 738) with videos related to

Pageof 74
Sort By:
Gynecologic Oncology|September 15, 2010
Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group studyDavid Cella, Helen Q Huang, Bradley J Monk, et al.
Gynecologic Oncology|July 2, 1998
Cervical cancer with paraaortic metastases: significance of residual paraaortic disease after surgical stagingP Y Kim, B J Monk, S Chabra, et al.
The Australian and New Zealand Journal of Psychiatry|August 22, 2024
The physical health and premature mortality of Indigenous Māori following first-episode psychosis diagnosis: A 15-year follow-up studyNathan J Monk, Ruth Cunningham, James Stanley, et al.
Gynecologic Oncology|December 17, 2013
Impact of facility volume on therapy and survival for locally advanced cervical cancerJeff F Lin, Jessica L Berger, Thomas C Krivak, et al.
Journal of Fish Biology|August 14, 2012
Aspects of the biology of Galaxias maculatusL J B Laurenson, R P French, P Jones, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 14, 2022
Proportions and incidence of locally advanced cervical cancer: a global systematic literature reviewBradley J Monk, David S P Tan, José David Hernández Chagüi, et al.
Gynecologic Oncology|May 5, 2012
Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancerThanh H Dellinger, Kestutis Planutis, Danielle D Jandial, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 15, 2023
Safety and management of niraparib monotherapy in ovarian cancer clinical trialsBradley J Monk, Antonio González-Martin, Lynn Buckley, et al.
Obstetrics and Gynecology|September 9, 2015
Disparities in Vulvar Cancer Reported by the National Cancer Database: Influence of Sociodemographic FactorsDana M Chase, Chun Chieh Lin, Christine D Craig, et al.
Gynecologic Oncology|July 1, 1994
Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinomaB J Monk, D S Cha, J L Walker, et al.
Pageof 74

Showing results (251-260 of 738) with videos related to

Sort By:
Pageof 74
Gynecologic Oncology|September 15, 2010
Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group studyDavid Cella, Helen Q Huang, Bradley J Monk, et al.
Gynecologic Oncology|July 2, 1998
Cervical cancer with paraaortic metastases: significance of residual paraaortic disease after surgical stagingP Y Kim, B J Monk, S Chabra, et al.
The Australian and New Zealand Journal of Psychiatry|August 22, 2024
The physical health and premature mortality of Indigenous Māori following first-episode psychosis diagnosis: A 15-year follow-up studyNathan J Monk, Ruth Cunningham, James Stanley, et al.
Gynecologic Oncology|December 17, 2013
Impact of facility volume on therapy and survival for locally advanced cervical cancerJeff F Lin, Jessica L Berger, Thomas C Krivak, et al.
Journal of Fish Biology|August 14, 2012
Aspects of the biology of Galaxias maculatusL J B Laurenson, R P French, P Jones, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 14, 2022
Proportions and incidence of locally advanced cervical cancer: a global systematic literature reviewBradley J Monk, David S P Tan, José David Hernández Chagüi, et al.
Gynecologic Oncology|May 5, 2012
Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancerThanh H Dellinger, Kestutis Planutis, Danielle D Jandial, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 15, 2023
Safety and management of niraparib monotherapy in ovarian cancer clinical trialsBradley J Monk, Antonio González-Martin, Lynn Buckley, et al.
Obstetrics and Gynecology|September 9, 2015
Disparities in Vulvar Cancer Reported by the National Cancer Database: Influence of Sociodemographic FactorsDana M Chase, Chun Chieh Lin, Christine D Craig, et al.
Gynecologic Oncology|July 1, 1994
Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinomaB J Monk, D S Cha, J L Walker, et al.
Pageof 74